Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Projecten
- 2 Afgelopen
-
EUAR33: H2020: CSA: EURAMED rocc-n-roll: Europese medische applicatie en stralingsbeschermings concept
1/09/20 → 31/08/23
Project: Fundamenteel
-
OZR3685: H2020: CSA: EURAMED rocc-n-roll: Europese medische applicatie en stralingsbeschermings concept (OZR EU BONUS)
1/09/20 → 31/08/23
Project: Fundamenteel
Onderzoeksoutput
-
18F-FDG PET/CT findings in an adult with diffuse hemangiomatosis mimicking diffuse metastasis on conventional radiology
Ardies, P. J., Muylle, K., Everaert, H., Goethals, L., Gykiere, P., Keyaerts, M. & Lahoutte, T., 5 mei 2017.Onderzoeksoutput: Poster
-
PET 20.0: a cost-efficient, 2mm spatial resolution Total Body PET with point sensitivity up to 22% and adaptive axial FOV of maximum 2.00m
Vandenberghe, S., Mikhalyova, E., Brans, B., Defrise, M., Lahoutte, T., Muylle, K., Van Holen, R., Schaart, D. R. & Karp, K. S., okt. 2017, In: European Journal of Nuclear Medicine and Molecular Imaging. 44, blz. S305-S305Onderzoeksoutput: Meeting abstract (Journal)
6 Citaten (Scopus) -
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
Muylle, K., Flamen, P., Vugts, D. J., Guiot, T., Ghanem, G., Meuleman, N., Bourgeois, P., Vanderlinden, B., van Dongen, G. A. M. S., Everaert, H., Vaes, M. & Bron, D., jul. 2015, In: European Journal of Nuclear Medicine and Molecular Imaging. 42, 8, blz. 1304-1314 11 blz.Onderzoeksoutput: Article › peer review
83 Citaten (Scopus) -
Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.
Muylle, K., Flamen, P., Vugts, DJ., Guiot, T., Ghanem, G., Meuleman, N., Bourgeois, P., Vanderlinden, B., van Dongen, GAMS., Everaert, H., Vaes, M. & Bron, D., 2015, In: European Journal of Nuclear Medicine and Molecular Imaging. 42, blz. 1304-1314Onderzoeksoutput: Article › peer review
-
Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2
Covens, P., Jamar, F. & Muylle, K., mrt. 2014, HGR/CSS redactie FOD Volksgezonheid, Veiligheid van de voedselketen en leefmilieu. 15 blz.Onderzoeksoutput: Commissioned report
Open Access
-
"Looks like the raccoon sign..." "baboon?""NO, RACCOON!!!"
Lynn De Mey (Speaker), Sophie Bourgeois (Speaker), Kristoff Muylle (Speaker), Jeroen De Filette (Speaker), Odrade Gondry (Speaker), Lode Goethals (Speaker), Amelientje Bracke (Speaker), Hendrik Everaert (Speaker) & Tony Lahoutte (Speaker)
7 mei 2022Activiteit: Talk or presentation at a conference
-
-
2017 BELNUC Highlights Lecture
Kristoff Muylle (Invited speaker)
7 mei 2017Activiteit: Talk or presentation at a conference